Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 2601 South Bayshore Drive, Suite 900 MIAMI FL 33133 |
Tel: | N/A |
Website: | https://www.ayrwellness.com |
IR: | See website |
Key People | ||
Jonathan E. Sandelman Executive Chairman of the Board | David Goubert President, Chief Executive Officer | Brad Asher Chief Financial Officer |
Jason Griffith Chief Operating Officer | Robert Mendola Head of Strategy and M&A |
Business Overview |
AYR Wellness Inc. is a vertically integrated multi-state cannabis operator in the United States. The Company operates simultaneously as a retailer with more than 90 licensed dispensaries and a house of cannabis consumer packed goods (CPG) brands. It is a cultivator, manufacturer and retailer of cannabis products and branded CPG, and is engaged in the manufacture, possession, use, sale, or distribution of cannabis and/or holds licenses in the adult-use and/or medicinal cannabis marketplace in the States of Massachusetts, Nevada, Pennsylvania, Florida, New Jersey, Ohio, Illinois, and Connecticut. The Company's portfolio of CPG brands includes Kynd, Origyn Extracts, Levia, STiX Preroll Co., Secret Orchard, and Entourage, among others. It owns and operates a chain of cannabis retail stores under various brand names. The Company distributes and markets its products to Company-owned retail stores and to third-party licensed retail cannabis stores throughout its operating footprint. |
Financial Overview |
For the three months ended 31 March 2024, Ayr Wellness Inc revenues increased less than 1% to $118M. Net loss before extraordinary items increased from $9.4M to $106.1M. Revenues reflect market conditions. Higher net loss reflects Fair value gain on financial liabilities decrease from $27.6M (income) to $0K, Interest expense increase from $7.6M to $17.6M (expense), Operating lease Expense increase of 16% to $4.5M (expense). |
Employees: | 2,300 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $936.12M as of Mar 31, 2024 |
Annual revenue (TTM): | $631.46M as of Mar 31, 2024 |
EBITDA (TTM): | $139.34M as of Mar 31, 2024 |
Net annual income (TTM): | -$248.77M as of Mar 31, 2024 |
Free cash flow (TTM): | -$4.99M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $484.90M as of Mar 31, 2024 |
Shares outstanding: | 114,878,763 as of May 2, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |